Tech Company Financing Transactions
Torbay Pharmaceuticals Funding Round
NorthEdge Capital and private investors participated in a funding round for Torbay Pharmaceuticals. The financing was announced on 11/20/2023.
Transaction Overview
Company Name
Announced On
11/20/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
NorthEdge Capital (Lead Investor)
private investors (Alex Griffiths)
Proceeds Purpose
The company intends to use the funds to strengthen its capabilities and expand its reach in North America, while continuing to grow and invest in its 250-strong team at its UK headquarters in Paignton, Devon.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Wilkins Drive, Paignton
Devon, TQ4 7FG
England
Devon, TQ4 7FG
England
Phone
Website
Email Address
Overview
Torbay Pharmaceuticals (Torbay) is a sterile injectable contract manufacturer and licence holder based in Paignton, UK. Established in the 1970s as part of the Torbay and Devon NHS Foundation Trust, Torbay has grown to a 250-strong team serving an international client base of healthcare organisations and pharmaceutical companies. It received investment from private equity firm NorthEdge in November 2023 and became Torbay Pharmaceuticals Ltd.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emma Rooth
Browse more venture capital transactions:
Prev: 11/20/2023: Scalestack venture capital transaction
Next: 11/20/2023: Cantai Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs